Grand Rounds – August 8, 2017
The University of Florida
Continuing Medical Education and Department of Neurology
“Transcriptomic and Epigenetic profiling of ALS Brains”
Veronique Belzil, PhD
Adjunct Professor, Department of Neurology/Neurosurgery, McGill University
Assistant Professor, Mayo Clinic
4500 San Pablo Road
Presentation will be in lecture format with Q & A following
Tuesday, August 8, 2017
McKnight Brain Institute, DeWeese Auditorium, LG-101
Upon completion of this activity, participants will be able to:
- Explain the central contribution of transcriptomic and epigenetic changes to both C9orf72-associated and sporadic amyotrophic lateral sclerosis
- Recognize the importance of identifying epigenetic-modifying factors that amyotrophic lateral sclerosis patients have been exposed to, possibly leading to misregulation of key biological mechanisms and disease onset
- Indicate the potential of drugs targeting the epigenetic machinery currently in use in the field of oncology to be developed for amyotrophic lateral sclerosis therapeutics
Dr. Belzil has disclosed that they have no relevant financial relationships. No one else in a position to control the content of this activity has any financial relationships to disclose.
The University of Florida College of Medicine is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.
The University of Florida College of Medicine designates this live activity for a maximum of 1 AMA PRA Category 1 Credit™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
Neurology Grand Rounds – Section # 8336